TAIMEI TECH Repurchases 1.30 Million H Shares for HKD 5.84 Million

Bulletin Express10-12

Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a new share buyback on 12 October 2026, acquiring 1.30 million H shares on the Hong Kong Stock Exchange for a total consideration of HKD 5.84 million.

The shares were repurchased at prices ranging between HKD 4.43 and HKD 4.55, with a volume-weighted average cost of HKD 4.51 per share. The transaction represents 0.67% of TAIMEI TECH’s issued share capital (excluding treasury shares) prior to the buyback.

Following the cancellation-pending repurchase, the company’s outstanding H shares declined to 191.84 million, while treasury holdings increased to 8.76 million. Total issued shares remain unchanged at 200.59 million.

The buyback forms part of the mandate approved by shareholders on 23 June 2026, which authorizes the company to repurchase up to 20.02 million shares. Cumulative repurchases under this mandate have reached 8.33 million shares, equivalent to 4.16% of the share count at the mandate date.

In accordance with Hong Kong Listing Rule 10.06, TAIMEI TECH is subject to a 30-day moratorium on issuing new shares or selling treasury shares, effective until 11 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment